A Phase I Dose-Ranging Study of the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of AVN944, an IMPDH Inhibitor, in Healthy Male Volunteers

2009 ◽  
Vol 49 (1) ◽  
pp. 30-38 ◽  
Author(s):  
J. Michael Hamilton ◽  
Matthew W. Harding ◽  
Thomas Genna ◽  
David K. Bol
Keyword(s):  
Phase I ◽  
Healthy Male ◽  
Healthy Male Volunteers ◽  
Male Volunteers ◽  
Dose Ranging

Multiple Rising Doses of Oral BI 1358894 in Healthy Male Volunteers: A Phase I Study to Investigate Safety and Tolerability

2020 ◽  
Vol 87 (9) ◽  
pp. S417-S418
Author(s):  
Markus Goettel ◽  
Lena Herich ◽  
Sabrina Wiebe ◽  
Rene Fuertig ◽  
Vikas Sharma ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Healthy Male ◽  
Healthy Male Volunteers ◽  
Male Volunteers

A Phase I clinical trial of lodenafil carbonate, a new phosphodiesterase Type 5 (PDE5) inhibitor, in healthy male volunteers

2012 ◽  
Vol 50 (12) ◽  
pp. 896-906 ◽  
Author(s):  
Gustavo D. Mendes ◽  
Hilton Oliveira dos Santos Filho ◽  
Alberto dos Santos Pereira ◽  
Fabiana D. Mendes ◽  
Jaime O. Ilha ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Pde5 Inhibitor ◽  
Phase I Clinical Trial ◽  
Healthy Male ◽  
Healthy Male Volunteers ◽  
Male Volunteers ◽  
Phosphodiesterase Type

A phase I study to determine the effect of tamoxifen on the pharmacokinetics of a single 250 mg oral dose of gefitinib (IRESSA) in healthy male volunteers

2005 ◽  
Vol 56 (6) ◽  
pp. 557-562 ◽  
Author(s):  
Mireille V. Cantarini ◽  
Merran P. Macpherson ◽  
Anna L. Marshall ◽  
Anna V. Robinson ◽  
Christopher J. Bailey
Keyword(s):  
Oral Dose ◽  
Phase I ◽  
Phase I Study ◽  
Healthy Male ◽  
Healthy Male Volunteers ◽  
Male Volunteers
Sign in / Sign up

Export Citation Format

Share Document